The effect of treatment on diaphragm contractility in obstructive sleep apnea syndrome  by El-Kabir, Desiree R. et al.
The effect of treatment on diaphragm
contractility in obstructive sleep apnea syndrome
Desiree R. El-Kabira,*, Michael I. Polkeyb, Rebecca A. Lyallc,
Adrian J. Williamsa, John Moxhamc
aLane Fox Respiratory Unit and Sleep Disorders Centre, St Thomas’ Hospital,
Guy’s King’s and St Thomas’ School of Medicine, Lambeth Palace Road, London SE1 7EH, UK
bRespiratory Muscle Laboratory, Royal Brompton Hospital, London SW3 6NP, UK
cRespiratory Muscle Laboratory, King’s College Hospital, Guy’s King’s and St Thomas’ School of Medicine,
Bessemer Road, London SE5 9RS, UK
Summary In untreated obstructive sleep apnea syndrome (OSAS) inspiratory efforts
are made against an occluded airway and diaphragm fatigue might therefore
complicate OSAS. To test this hypothesis we measured twitch transdiaphragmatic
pressure (Tw Pdi) in response to bilateral cervical magnetic stimulation of the phrenic
nerve roots in nine patients with OSAS before and one month after successful therapy
with nasal continuous positive airways pressure (nCPAP). The mean Tw Pdi before
therapy was 23.2 cm H2O and after therapy was 22.8 cm H2O (P ¼ 0:59); the mean
change after initiation of nCPAP was 0.4 cm H2O with 95% confidence intervals of
1.3 cm H2O and þ 2.1 cm H2O. We conclude that low frequency diaphragm fatigue
does not complicate untreated OSAS.









Obstructive sleep apnea syndrome (OSAS) is a
common condition1 which, in mild to moderate
disease may result in significant daytime somno-
lence; however in severe disease ventilatory
failure is a recognized complication.2 During
obstructive apneas substantial intrathoracic pres-
sures may be generated and in some patients the
pressure time index may exceed the level of 0.18
where diaphragm fatigue may be expected to
occur.3 Previous groups have hypothesized that
the load placed on the diaphragm during sleep
would generate fatigue. The techniques used to
test this hypothesis have included measurement of
transdiaphragmatic pressure (Pdi), relaxation rate
and power spectral analysis of the diaphragm EMG.
However, perhaps because of the variety of
methods used, the published data have not
conclusively confirmed or refuted the hypoth-
esis.4–6 Moreover, none of these studies have used
methods adequate to detect the presence of low-
frequency fatigue, which is the form of fatigue
currently postulated to be of clinical relevance.
The method most suitable for clinical studies of
diaphragm fatigue is the measurement of twitch
transdiaphragmatic pressure (Tw Pdi) in response to
single supramaximal bilateral phrenic nerve stimu-
lation.7 Tw Pdi has been demonstrated to fall when
low-frequency diaphragm fatigue is induced in
normal humans8 and recovers over a period of
hours.9 This observation, particularly the long
period required for recovery, is consistent with
data obtained from other human muscles.10 In this
study we tested the hypothesis that patients with
OSAS have low-frequency diaphragm fatigue; if this
hypothesis were correct then successful treatment
with nasal continuous positive airways pressure
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Nine subjects with moderate OSAS were recruited.
None of the patients had clinical evidence of
neuromuscular disease, pre-existing respiratory or
cardiac disease or other conditions pre-disposing to
sleep-disordered breathing. All subjects gave their
written informed consent. Ethical approval was
granted by the hospital ethics committee.
Diagnosis and management of OSAS
The diagnosis of OSAS for this study required an
appropriate history, excessive daytime sleepiness
and a diagnostic sleep study. In six cases (Subjects
no. 1, 2, 4, 5, 7 and 9) this was a polysomnographic
study and in the remaining three subjects overnight
oximetry. Polysomnography was performed in a
sleep laboratory according to the standards of the
American Sleep Disorders Association using the
Somnostar Alpha apparatus (Sensormedics Inc,
Yorba Linda, CA) and studies were manually scored
according to standard criteria.11 Overnight oxime-
try was performed in the patients own home
using the Ohmeda 3700 Biox oximeter (Ohmeda
Inc, CO). All patients had an apnea-hypopnea index
(AHI) or oxygen desaturation index (ODI) of greater
than 10 events per hour; the mean (SD) AHI
being 27.6 (14.6) and the mean ODI 32.8 (10.6)
events/h.
The patients were treated with nCPAP; the
optimal level of CPAP was determined by an
automated titration study (Autosets, Resmed,
Abingdon, UK). All patients accepted nCPAP ther-
apy and obtained satisfactory symptomatic relief
with dramatic reduction of symptoms, which in all
cases persisted for a minimum of four months at
routine follow-up. We also recorded the Epworth
sleepiness score (ESS) in all subjects before and
after nCPAP therapy; the mean pretreatment value
was 16.4 (3.5) and on the day of repeat study was
6.7 (3.2) (P ¼ 0:001).
Inspiratory muscle strength tests
Inspiratory muscle contractility was evaluated at
the same time each morning (generally 9 am) both
before and after at least 1 month of nCPAP
treatment. Two balloon-tipped catheters (PK
Morgan, Rainham, Kent, UK) 110 cm in length were
passed through the nose under topical anesthesia;
one was positioned in the mid-esophagus and the
other in the stomach. The catheters were con-
nected to differential pressure transducers (Vali-
dyne MP45-1; Validyne, Northridge CA), carrier
amplifiers (PK Morgan, Rainham, Kent UK), a 12-
bit NB-MIO-16 analogue-digital board (National
Instruments, Austin, TX) and a Macintosh Quadra
Centra 650 personal computer (Apple Computer
Inc, Cupertino, CA) running Labviewt software
(National Instruments). Signals were sampled at
100 Hz. The subtraction of the esophageal pressure
(Pes) from the gastric pressure (Pga) allowed the
Pdi to be calculated.
All subjects were rested for 20min with the
catheters in place to minimize twitch potentia-
tion12 prior to respiratory muscle strength testing.
Diaphragm strength was measured as Tw Pdi
following cervical magnetic stimulation of the
phrenic nerve roots at the back of the neck at the
level of the 7th cervical vertebra.13 A 19-pin,
90-mm circular coil was used powered by a Magstim
DEM stimulator (Magstim Co., Whitland, Dyfed,
UK). The optimal site for stimulation was first
determined with the magnetic stimulator at 70%
maximal output, and was then marked. A minimum
of five stimulations at 100% output were then
performed from relaxed end-expiration judged
from Pes with the subject seated and wearing a
noseclip. The mean Tw Pdi of these five stimula-
tions was then used for further analysis.
In addition diaphragm strength was assessed
volitionally by the measurement of Pdi during a
maximal voluntary sniff, sniff transdiaphragmatic
pressure (Sn Pdi).14 The subjects were instructed to
perform at least 10 short sharp maximal sniff
manoeuvres from FRC and the maximal Sn Pdi
value was recorded. Global inspiratory muscle
strength was measured as the maximal sniff
esophageal pressure (Sn Pes) obtained in this
way.15 During these volitional tests the pressure
trace obtained was visible to the subject and the
investigator provided verbal encouragement. The
pressure measured at the mouth during a maximal
static inspiratory effort against an occlusion (PI-
max) was also recorded. We used a flanged mouth-
piece, which was held by the investigator and this
test was performed from RV.
Statistics
Paired t-tests were used to compare respiratory
muscle tests before and after treatment with
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nCPAP. The statistical calculations were performed
in Stata (Stata Corporation, College Station, TX)
and a level of Po0:05 was taken as significant.
Results
Clinical data from the nine subjects is shown in
Table 1. Eight of the nine subjects were male and
the mean (SD) age was 48.0 (10.1) years. The mean
(SD) body mass index (BMI) was 36.7 (8.2) and seven
subjects were clinically obese (BMI430 kg/m2).
Using the criterion of an ESS greater than 10, all
subjects were pathologically sleepy, the mean (SD)
pretreatment score being 16.4 (3.5). Data from
polysomography from five subjects showed a mean
(SD) total sleep time of 372.6 (82.0)min. The
mean sleep latency was 15.9 (14.4)min and
the mean sleep efficiency 78.8 (15.3)%. Mean
latency to the onset of rapid eye movement (REM)
sleep was 64.3 (47.9)min. The mean distribution of
sleep stages was as follows: Stage 1: 8.3 (4.2)%;
Stage 2: 54.1 (17.1)%; Stage 3: 11.4 (5.3)%; Stage 4:
0.4 (0.6)% and Stage REM: 10.8 (7.1)%.
Efficacy of therapy was confirmed by the marked
improvement in symptoms of nocturnal disturbance
and daytime sleepiness in all cases after initiation
of nCPAP therapy. This was further demonstrated by
a fall in the ESS to a mean (SD) value within the
normal range of 6.7 (3.2) (P ¼ 0:001) (Fig. 1).
Subsequent outpatient review confirmed that all
subjects continued to use their nCPAP machines
regularly (follow up ranged from 4 months to 5
years).
Tw Pdi was inversely related to BMI (r2 ¼ 0:44;
P ¼ 0:051) and Sn Pdi (r2 ¼ 0:41; P ¼ 0:06) although
these trends did not reach statistical significance,
presumably because of the small number of
subjects studied. There was no relationship be-
tween Sn Pdi and BMI (r2 ¼ 0:08; P ¼ 0:46).
Respiratory muscle strength before and after
nCPAP is shown in Table 2. There was no significant
change in inspiratory strength following nCPAP
therapy whichever measure was used. In particular
for the primary outcome measure (Tw Pdi) the
mean value before therapy was 23.2 and 22.8 cm
H2O after therapy (P ¼ 0:59); the mean difference
was therefore 0.4 cm H2O with 95% confidence
intervals of 1.3 cm H2O and þ 2.1 cm H2O (Fig. 2).
Thus the greatest rise in Tw Pdi that could have
been missed by chance in this study was 1.3 cm H2O
or 5.6%.
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ESS AHI or ODI (events/h) nCPAP pressure
(cm H2O)
1 M 54 28.5 121 16 37.4 8
2 M 63 32.9 97 13 22.2 12
3 M 30 36.4 56 19 23.2 14
4 F 59 46.8 44 12 23.0 9
5 M 56 42.9 93 17 20.0 14
6 M 45 32.9 98 20 44.2 14
7 M 42 51.8 95 15 52.0 13.5
8 M 44 32.7 39 23 31.1 12
9 M 39 25.6 115 13 11.0 9.5
Mean (SD) 48(10.1) 36.7(8.2) 84.1(28.7) 16.4(3.5) 27.6(14.6) 32.8(10.6) 11.8(2.2)

















Figure 1 Epworth sleepiness scores (ESS) before and
after nCPAP therapy. Individual data are shown together
with the means and standard deviation.
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Discussion
The present study shows that effective treatment
of subjects with OSAS with nCPAP does not result in
an increase in Tw Pdi. It is therefore inferred that
repeated episodes of upper airway occlusion of the
severity seen in obstructive sleep apnea are
insufficient to generate diaphragm fatigue. A
discussion of the significance of the findings follows
a critique of the method.
Critique of the methods
The mean Tw Pdi (22.3 cm H2O) was slightly less
than in previous studies on normal subjects.16 It is
therefore probable that despite stimulation at 100%
of magnetic stimulator output, activation was not
maximal. Increased soft tissue of the neck and
upper back may have reduced that effectiveness of
the cervical stimulation. Nevertheless, the critical
issue is constancy of stimulation and providing
stimulation is reproducible, submaximal stimula-
tion can reliably detect diaphragm fatigue.10 The
variation between pre- and post-treatment values
was not greater in the more obese subjects and we
doubt therefore that this prevented the observa-
tion of a genuine rise in Tw Pdi after the institution
of nCPAP.
The validity of the study rests on the patients
having OSAS, and on nCPAP successfully treating the
OSAS and the patients being compliant with
therapy. Diagnostic studies using pulse oximetry
are limited by the inability to identify and stage
sleep and may also fail to accurately differentiate
between obstructive and central apneas. Previous
studies have shown that the sensitivity and speci-
ficity of oximetry for identifying OSA is dependent
on the AHI. When screening patients with an AHI of
X10 events/h, a sensitivity of 78% and specificity
of 100% has been reported for oximetry.17 In each of
the three cases overnight oximetry revealed the
repetitive saw-tooth desaturations characteristic
of OSA. Furthermore, the automated nCPAP titra-
tion studies performed added confirmatory evi-
dence of the existence of OSAS in all subjects
studied.
A potential weakness of the study was the lack of
repeat polysomnography and compliance data after
the introduction of nCPAP therapy. However, the
automated titration studies ensured that the
correct pressure of nCPAP was selected which
abolished apneic activity altogether. The subjects
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Table 2 Respiratory muscle strength before and after nCPAP therapy.
Patient no. Tw Pdi (cm H2O) Sn Pdi (cm H2O) Sn Pes (cm H2O) PImax (cm H2O)
Pre Post Pre Post Pre Post Pre Post
1 38.9 36.3 151.7 156.6 125.4 122.7 83.0 80.0
2 17.4 13.7 129.5 93.9 101.6 87.2 98.4 153.7
3 25.5 25.7 123.8 136.0 80.9 105.0 74.6 80.3
4 11.8 11.7 102.8 83.5 61.3 47.2 39.1 18.0
5 21.1 20.1 98.6 127.4 74.2 77.0 72.0 76.7
6 30.6 31.4 173.0 206.0 70.8 93.9 92.4 81.3
7 17.1 15.7 122.7 118.0 108.5 102.0 76.9 65.9
8 20.2 20.6 77.0 88.2 60.0 74.1 52.5 12.8
9 26.1 29.9 116.7 130.8 100.7 116.9 84.3 92.9
Mean (SD) 23.2 (7.7) 22.8 (8.1) 121.8 (26.9) 126.7 (36.2) 85.3 (22.3) 88.6 (21.5) 73.6 (18.4) 71.1 (40.9)
Tw Pdi, twitch transdiaphragmatic pressure; Sn Pdi, sniff transdiaphragmatic pressure; Sn Pes, sniff esophageal pressure; PImax;















Figure 2 Twitch transdiaphramatic pressure (Tw Pdi)
before and after nCPAP therapy. Individual data are
shown together with the means and standard deviation.
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were chosen to participate in the study only if they
had been compliant with the nCPAP therapy 1
month after its initiation. In addition, nCPAP
therapy in all cases lead to a dramatic reduction
in daytime sleepiness and returned the ESS to the
normal range. Furthermore, at longer term follow
up ranging between 4 months and 5 years, all
subjects continued to use nCPAP, supporting the
clinical value of the therapy.
We took great care to perform pre- and post-
treatment studies at the same time of day because
there is some evidence of a diurnal variation in
skeletal muscle strength. Morning to evening
variation has been measured in limb muscle, and
tension found to be up to 8.9% higher in the evening
whether measured by twitch, tetanic or maximal
voluntary contractions.18 For the respiratory mus-
cles there are no data on twitch pressures, but
mouth pressures were not found to exhibit diurnal
variation in 16 healthy men studied by Aguilar
et al.19
A second concern could be that low-frequency
fatigue had resolved by the time the subjects were
studied. The time interval between coming off
nCPAP and attending the laboratory was approxi-
mately 2 h. A previous study from our own
laboratory, in which low-frequency fatigue of the
diaphragm was induced by 2min of maximal
isocapnic ventilation demonstrated some resolution
of Tw Pdi within this time frame.20 However, in
another study, in which fatigue was induced using
inspiratory resistive loading (a mechanism perhaps
more appropriate to the situation in OSAS) a
significant reduction in Tw Pdi was evident even
after 24 h.9
Significance of the findings
The current data may represent an extension of our
understanding of ventilatory failure. Ventilatory
failure, as evidenced by carbon dioxide retention,
is a recognized sequelae of longstanding severe
OSAS.21 One mechanism for this could be the
development of inspiratory muscle fatigue. Our
data from subjects with moderate to severe OSAS
who have not yet developed ventilatory failure
suggest that this is probably not the responsible
mechanism in patients with OSAS.
The role of inspiratory muscle fatigue in ventila-
tory failure is disputed. It is well recognized that
the respiratory muscles can show changes consis-
tent with extreme loading (for example slowing of
the relaxation rate22 or EMG power spectrum23).
Similarly heavy loading in normal subjects, whether
in the form of whole body exercise or a task limited
to the respiratory system, can lead to overt low-
frequency fatigue as judged by a reversible fall in
Tw Pdi.20 It is less clear however whether low
frequency fatigue contributes to ventilatory failure
in practice. In this context the present data add to
our previous studies in COPD24,25 which also failed
to find evidence of diaphragm fatigue in a clinical
setting. In the case of COPD we attributed this, in
part, to the protective effect of diaphragm short-
ening on the fatiguability of the muscle. This
mechanism could not account for the lack of
fatigue in untreated patients with OSAS. A more
likely explanation in OSAS is a reduction in central
respiratory drive due to abnormalities of central
control, for example a blunting of central chemo-
sensitivity. However, the failure to demonstrate
low-frequency fatigue in OSAS reinforces the need
for future studies of ventilatory failure to use
the technique of phrenic nerve stimulation to
confirm or refute the presence of low-frequency
fatigue in clinical situations such as weaning fail-
ure, in which fatigue is currently considered to be
relevant.
In summary, in subjects with OSAS treatment
with nasal nCPAP despite resolving clinical symp-
toms failed to result in an increase in Tw Pdi. It is
concluded that diaphragm fatigue in this study did
not complicate OSAS.
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